InvestorsHub Logo

Just the facts maam

04/01/19 4:40 AM

#8932 RE: dasgrunt #8930

Good observation Dasgrunt. I think the corporate presentation is the only mention of it. I know they announced paying Teva $16 million to buyout their royalty commitment to Teva for 10 drugs in February. But nothing about these drugs.

Pipeline keeps deepening.

Hopefully the 10 Teva drug have already been launched and this will increase EPS above analyst estimates for Q1.